Orexigen Therapeutics, Inc. Company Profile

14:36 EDT 19th March 2018 | BioPortfolio

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Further information about the Company can be found at

News Articles [772 Associated News Articles listed on BioPortfolio]

Orexigen’s Weight-Loss Roller Coaster to End With a Bankruptcy Sale

Orexigen Therapeutics has filed for bankruptcy to sell its weight loss pill to the highest bidder. The news follows years of ups and downs for Orexigen, which piled up debt as it struggled to successf...

Orexigen Therapeutics: Umschuldung in 2018 fast zwingend

Orexigen habe ich in diesem Jahr ein paar mal gehandelt. Wie bei den meisten Biopharma-Werte sind ein paar ordentliche Sprünge erfolgt. Tendenz abwärts. Orexigen hat im Jahr 2016 die Vertriebsrecht....

Orexigen Therapeutics Announces Third Quarter 2017 Financial Results

Orexigen Therapeutics Recent Business Highlights: Drove 26% increase in Contrave® (naltrexone HCl / bupropion HCl extended release) total prescription volume in the United Statesin Read mor...

Anti-Obesity Drugmaker Orexigen Therapeutics Files for Bankruptcy

Shares of weight-loss drugmaker Orexigen Therapeutics are in free-fall this morning after the company announced it filed for bankruptcy.

Orexigen Therapeutics: 2018: Jahr der Entscheidung

Update Vorheriger Artikel: 35% brachte die Verkaufsempfehlung von mir vom 01.12.2017. Glückwunsch an alle!.....

Merck KGAA to market Orexigen's Contrave in Latin America

Orexigen Therapeutics Inc. penned a deal with Merck KGAA for marketing and distribution of Orexigen's obesity drug Contrave (burpropion/naltrexone) in Latin America (including Brazil, Mexico, Argentin...

Orexigen Bankruptcy Shows Difficulty of Marketing Weight-Loss Drugs

Drugmaker Orexigen Therapeutics Inc. filed for bankruptcy protection on Monday and plans to sell itself, after failing to find a profitable market for its weight-loss treatment Contrave.

Orexigen Therapeutics (OREX) - Driven by DTC

Edison Investment Research - Pharmaceutical & healthcare - Orexigen Therapeutics: Contrave sales took a bit of a breather during Q317, which is considered part of the off-season for obesity drugs, wit...

PubMed Articles [404 Associated PubMed Articles listed on BioPortfolio]

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Eyes on New Product Development: Preclinical Research.

Introduction to Volume 2 of JOPT Special Issue.

Introduction to Volume 1 of JOPT Special Issue.

Clinical Trials [134 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1201 Associated Companies listed on BioPortfolio]

Orexigen Therapeutics, Inc.

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Further information about the Company can be found at

Blue Chip Marketing Worldwide

Blue Chip Marketing Worldwide (, this year celebrating its 30th anniversary, is an independent, full-service global marketing agency that delive...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Orexigen Therapeutics, Inc." on BioPortfolio

We have published hundreds of Orexigen Therapeutics, Inc. news stories on BioPortfolio along with dozens of Orexigen Therapeutics, Inc. Clinical Trials and PubMed Articles about Orexigen Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Orexigen Therapeutics, Inc. Companies in our database. You can also find out about relevant Orexigen Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Corporate Database Quicklinks

Searches Linking to this Company Record